BR100 Decreased By (-0.23%)
BR30 Decreased By (-0.01%)
KSE100 Decreased By (-0.19%)
KSE30 Decreased By (-0.24%)
AGHA 7.74 Increased By ▲ 0.05 (0.65%)
BECO 5.29 Decreased By ▼ -0.02 (-0.38%)
BML 60.01 Decreased By ▼ -1.22 (-1.99%)
BOP 36.46 Increased By ▲ 0.46 (1.28%)
CNERGY 11.94 Increased By ▲ 0.69 (6.13%)
CSIL 6.17 No Change ▼ 0.00 (0%)
FCCL 57.36 Increased By ▲ 0.48 (0.84%)
FFL 16.58 Increased By ▲ 0.07 (0.42%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.32 Decreased By ▼ -0.10 (-1.35%)
KOSM 6.05 No Change ▼ 0.00 (0%)
LOTCHEM 27.14 Decreased By ▼ -0.06 (-0.22%)
MLCF 102.07 Decreased By ▼ -1.02 (-0.99%)
NBP 206.35 Decreased By ▼ -1.28 (-0.62%)
NCPL 62.62 Increased By ▲ 0.70 (1.13%)
NPL 71.98 Decreased By ▼ -0.20 (-0.28%)
OGDC 319.19 Increased By ▲ 0.70 (0.22%)
PACE 11.38 Increased By ▲ 0.32 (2.89%)
PAEL 43.88 Decreased By ▼ -0.50 (-1.13%)
PIBTL 16.84 Decreased By ▼ -0.06 (-0.36%)
PPL 221.55 Decreased By ▼ -0.93 (-0.42%)
PRL 63.75 Decreased By ▼ -0.06 (-0.09%)
PTC 72.41 Decreased By ▼ -0.75 (-1.03%)
SSGC 27.28 Increased By ▲ 0.03 (0.11%)
TBL 9.86 Decreased By ▼ -0.02 (-0.2%)
TELE 8.62 Decreased By ▼ -0.19 (-2.16%)
TPL 20.68 Increased By ▲ 0.34 (1.67%)
TPLP 14.98 Increased By ▲ 0.01 (0.07%)
TREET 24.10 No Change ▼ 0.00 (0%)
TRG 63.29 Increased By ▲ 0.92 (1.48%)

KARACHI: In line with our vision to be trusted global healthcare partner - CCL in Vietnam has ventured into an exclusive marketing and distribution agreement, leading to a joint venture, with AJRP Malaysia – a Global Healthcare Conglomerate”, shares Atif Siddiqui, President CCL Life Sciences.

The contract was signed on 1st April 2021 by Jaudat Amin – Business Head CCL South East Asia and D.S. Jamil Bidin – CEO AJRP Malaysia. CCL envisions to meet everyday health, nutrition, home and personal care needs of a billion people in developing countries – making them happy, feel good and get more out of life. To be able to do so, we aspire to be trusted global healthcare partners, offering unique solutions for all stages of life.

CCL has a legacy of over 50 years, with a global footprint in 22 countries and counting. We specialize in pharmaceuticals, consumer healthcare, food and nutrition and digital health products. Our strategic partners have a proven track record of over 70 years, operating in healthcare, life sciences, food and beverage, oil and gas and the automotive sector. Together, we aim to bring quality life products to our consumers, and contribute towards strengthening the Global Consumer Healthcare portfolio in the region.—PR

Copyright Business Recorder, 2021

Comments

Comments are closed for this article.